Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 1,190 | 1,630 | 1,260 | 1,500 | 970 |
| TOTAL | $1,190 | $1,630 | $1,260 | $1,500 | $970 |
| Non-Current Assets | |||||
| PPE Net | 1,040 | 700 | 880 | N/A | N/A |
| Other Non-Current Assets | 10,790 | 13,670 | 6,970 | 7,260 | 8,570 |
| TOTAL | $11,830 | $14,370 | $7,850 | $7,260 | $8,570 |
| Total Assets | $13,020 | $16,000 | $9,110 | $8,760 | $9,540 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 0 | 0 | 70 |
| Accounts payable and accrued liabilities | 8,490 | 10,100 | 5,270 | 7,640 | 5,120 |
| Other current liabilities | 80 | 60 | 20 | 2,690 | 0 |
| TOTAL | $8,570 | $10,160 | $5,290 | $10,330 | $5,190 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,060 | 6,520 | 1,910 | 40 | 2,450 |
| TOTAL | $1,060 | $6,520 | $1,910 | $40 | $2,450 |
| Total Liabilities | $9,630 | $16,680 | $7,200 | $10,370 | $7,640 |
| Shareholders' Equity | |||||
| Common Shares | 350 | 290 | 220 | 150 | 120 |
| Other shareholders' equity | 40 | 20 | -580 | 0 | 0 |
| TOTAL | $473,030 | $465,320 | $450,140 | $426,300 | $401,760 |
| Total Liabilities And Equity | $482,660 | $482,000 | $457,340 | $436,670 | $409,400 |